glp-1 landscape Clinical Focus on Agonists in Type 2 Diabetes Mellitus The Medicine Maker | Insights

FACLM A new class of weight-loss drugs has received enormous, almost unprecedented attention in the mainstream media and business press

We also need to be aware of medication that people might be trying to personally import there is no quality control with products they might be buying online and overseas

The survey was performed during April and May of 2025

Lower GLP-1 use among adults ages 65 and older, including for weight loss, may reflect Medicares lack of coverage for prescription drugs used specifically for weight loss

Potential Benefits of Ozempic for Athletes There are benefits and risks that athletes need to understand before opting for Ozempic, Wegovy, or other GLP-1 weight loss drugs